Since the discovery of BCR/ABL translocation and the specific cytogenetic marker, Philadelphia chromosome, resulted from the translocation t(9;22)(q34;q11), chronic myeloid leukemia is a separate entity and a distinct disease. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.